Three significant CMS proposed rules hit the Federal Register in the week of October 20, 2026, each with a December 15 comment deadline, giving practices roughly 53 days to weigh in or adjust operational plans.
Implementing Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act 2026, this rule would apply to Contract Year 2028 and would require:
For revenue cycle, the practical effect arrives in 2028 formulary design: if rebate pass-through reduces the cost of generics at the plan level, payer formulary tiers may shift in ways that affect prior authorization requirements for branded agents and Part B drug coverage policies.
CMS proposed that Medicare Advantage plans must verify provider directory accuracy at least every 90 days and update listings within 30 days of changes. Plans would publish an annual accuracy score. For practices, the key implication is that directory errors will be identified and corrected faster — reducing the “directory correct, auth denied” cycle that billing teams encounter when patients present with plans listing an out-of-network provider as in-network.
| What Changes | Practice Impact |
|---|---|
| 90-day mandatory directory verification cycle | Faster correction of erroneous in-network listings |
| 30-day update window after provider data change | Less time between practice address/contact changes and directory accuracy |
| Annual accuracy score published by each plan | New performance signal for practice-level network monitoring |
The Federal Register notice at 2026-21420 implements additional Medicare provisions from the Consolidated Appropriations Act 2026. The broader CAA 2026 framework has been reshaping MA marketing requirements, SOA waiting periods, and enrollment safeguards throughout 2026. Comments are due December 15.
Log all three December 15 comment deadlines now. Even if you do not submit formal comments, reviewing the proposed rules identifies rule changes that will affect your contract terms, formulary management, and directory maintenance protocols starting in 2028.
UnitedHealth and Humana are ending Medicare Advantage plans for roughly 1 million enrollees heading into the 2027 plan year — directly affecting patient eligibility and authorization workflows — while Amazon, Meta, Google, Oracle, and Axon Enterprise joined the federal Prior Authorization Pledge. The electronic PA mandate’s FHIR API go-live is now 70 days away.
UnitedHealth is discontinuing MA plans affecting approximately 390,000 members, and Humana is cutting plans affecting roughly 600,000 enrollees — totaling nearly 1 million patients entering the open enrollment period (October 15 – December 7) who must choose a new plan for 2027. Leerink Partners analysis also found broad benefit trims at Aetna and Centene.
For billing teams, this creates a dense eligibility workflow in Q4:
A plan exit is not a mid-year disenrollment — coverage continues through December 31 under the old plan. But January 1 claims will process under the new plan only. Every affected patient must be re-verified before the first appointment of 2027, not just before December 7.
CMS announced that Amazon, Axon Enterprise, Meta Platforms, Google, and Oracle signed the Prior Authorization Pledge, joining major payers who committed in 2025. The pledge targets standardization for common services including imaging and orthopedic surgery. Pledge signatories collectively reported an 11% reduction in overall PA volume in the nine months since the original commitment.
The CMS interoperability rule requiring FHIR-based electronic prior authorization APIs for payers takes effect January 1, 2027. Confirm with your EHR/PM vendor whether your system can submit structured FHIR PA requests. Practices that can transmit structured requests will see faster turnaround once payers activate the API.
HFMA research finds 67% of healthcare organizations identify AI and automation as the functions that will drive the most significant impact on denials and underpayment management over the next 12 months. The practical architecture is now three-tiered: RPA handles fixed rules, predictive AI scores claims before submission, and agentic AI manages multi-step exception workflows.
| Use Case | AI Approach | Maturity |
|---|---|---|
| Eligibility verification | RPA + ML for edge cases | High — widely deployed |
| Pre-submission claim scrubbing | Predictive scoring | High — major vendors |
| Denial prevention (upstream) | Predictive + documentation AI | Growing |
| Autonomous coding | Generative AI + human review | Moderate — inpatient early |
| Appeal generation | Generative AI | Emerging |
| Payment posting and reconciliation | RPA + ML | High |
UCHealth paid $23 million in November 2024 to settle DOJ allegations tied to automated coding of emergency department claims — a reminder that AI coding systems require active human audit protocols, not just initial configuration. Every autonomous coding or agentic workflow deployment needs a governance framework covering audit frequency, exception routing, and override documentation.
The 53-point gap between organizations that believe AI could reduce denials (67%) and those actively using it (14%) represents a significant revenue opportunity. The barrier is not technology availability — it is workflow integration, staff training, and governance design.
The FY 2027 ICD-10-CM update — effective October 1, 2026 through September 30, 2027 — is now in its fourth week of claims production. The code set adds 190 new billable codes with 30 codes losing billable status, plus revisions affecting staging logic for several oncology and chronic disease categories.
The D05 code category (carcinoma in situ of breast) has been revised: you should no longer report D05 codes together with C50 breast cancer codes when a patient has both conditions in the same encounter. This change directly affects oncology and surgery practices — claims that retain the prior dual-code approach will likely generate claim adjustment reason codes.
| Category | What Changed | Action |
|---|---|---|
| D05 Breast DCIS + C50 | No longer code both together in same encounter | Audit oncology October claims for dual-code combinations immediately |
| ICD-10-PCS FY 2027 | Applies Oct 1, 2026 – Mar 31, 2027 for inpatient discharges | Update inpatient coding protocols at skilled facilities |
| 30 defunct codes | Billable status removed October 1 | Run crosswalk audit; legacy codes on encounter forms will generate rejections |
| 190 new codes | Available but only when documentation supports specificity | Train coders on new specificity options, especially for chronic and oncology diagnoses |
If your practice has not yet run an ICD-10-CM crosswalk audit on encounter forms, charge capture templates, and EHR order sets, do it this week. Four weeks of volume already carry any legacy codes that should have been retired — the compounding effect grows every week.
2026 benchmark data from multiple industry sources converge on tighter targets than prior years, reflecting the productivity dividend from AI-assisted RCM. These figures now represent the standard for a competitive, efficient independent practice — not the ceiling.
| KPI | Best Practice | Industry Average | Warning Threshold |
|---|---|---|---|
| Days in Accounts Receivable | 30–40 days | 40–50 days | >60 days |
| Clean Claim Rate | 97–98%+ | 90–95% | <90% |
| Denial Rate | <5% | 10–15% | >20% |
| Net Collection Rate | 96–99% | 90–95% | <90% |
| A/R Over 90 Days | <15% of total A/R | 20–25% | >30% |
| First-Pass Resolution Rate | >90% | 75–80% | <70% |
Two factors are simultaneously raising the bar. First, the CAQH 2024 Index documents that automation eliminated $258 billion in administrative costs across the healthcare industry — meaning the industry’s administrative efficiency frontier has permanently shifted. Second, denial rates are rising industry-wide: the average is now 10–15% with some estimates putting 2025 at 12%, driven by MA plan complexity and prior authorization volume.
A 3-percentage-point improvement in clean claim rate (from 94% to 97%) on a practice billing $5M annually recaptures approximately $150,000 in first-pass revenue that would otherwise route through a denial cycle costing 6–8% in rework overhead.
Black Book Research’s 2026 annual client-rated RCM vendor report — profiling 420 vendors across hospital, health system, and inpatient provider categories — named its category leaders in June 2026. This week, Becker’s reported that Intermountain Healthcare has committed to R1 RCM’s Revenue Capture module on a systemwide basis.
| Category | Top-Rated Vendor | Key Differentiator |
|---|---|---|
| Full Provider Cloud RCM Suite | Inovalon | Enterprise data integration + payer analytics |
| Agentic AI & Autonomous RCM | Waystar | AltitudeAI platform, Google Cloud/Gemini integration |
| Denial Prevention & Analytics | AKASA | Inpatient autonomous coding + denial management AI |
| Patient Access & Financial Experience | Multiple (per Black Book front-end report) | Eligibility, scheduling, patient engagement |
Waystar’s AltitudeAI platform — expanded in August 2026 — spans all three RCM automation tiers including autonomous claim resolution, conversational performance analytics via Google Cloud/Gemini, AI-assisted clinical documentation tied to coding, and patient financial engagement.
Intermountain’s systemwide R1 commitment signals that mid-market RCM platform consolidation is accelerating. Independent practices evaluating EHR-integrated vs. best-of-breed RCM should factor in whether their current PM/EHR vendor is positioning for acquisition in this cycle.
Three compliance items converged at the federal and state level this week: the FY 2027 IPPS final rule activated updated FHIR standards on October 1; Illinois SB 63 is now law; and Colorado HB26-1139 is 69 days from effective date.
The FY 2027 IPPS final rule (published August 4, 2026) finalized updated FHIR data exchange standards effective October 1, 2026. The standards now cover:
Separately, CMS proposed (in CMS-0062-P, April 2026) requiring payers to report API endpoints to CMS annually or within 7 days of changes — meaning CMS will maintain a live registry of payer FHIR endpoints. Comments on that proposal closed June 15.
Illinois SB 63 (effective October 1, 2026): Bars insurers from making coverage determinations based solely on AI. Any AI-driven decision on coverage must have a clinician review step. Illinois payer denials coded as automated reviews may now be challenged on procedural grounds if no clinician sign-off is documented.
Colorado HB26-1139 (effective January 1, 2027): Bans AI-driven denials without a clinician’s independent opinion. This law is 69 days from effect — practices billing Colorado payers should review their denial management workflows for any automated-denial reversal process that relies on the payer having used a clinician review.
If you have pending Illinois or Colorado payer appeals based on automated denial decisions made after October 1 (Illinois) or January 1 (Colorado), document the lack of clinician review at the payer level — this is now a potential procedural defect in the denial that may support reversal.
The Veradigm 2026 State of Independent Practice survey (360 independent practice leaders) shows escalating financial stress combined with a structural revenue visibility gap — a dangerous combination heading into a period of plan exits, coding transitions, and rising denial rates.
| Metric | Independent Avg. | Health System Avg. | Target for Independence |
|---|---|---|---|
| Days in AR | 42–48 days | 35–40 days | ≤40 days |
| Clean Claim Rate | 90–93% | 94–97% | ≥95% |
| Denial Rate | 13–18% | 9–12% | ≤10% |
| Revenue Visibility (A/R by payer) | Low/None — 76% | High — most systems | Dashboard by payer, updated weekly |
| MA Open Enrollment Re-verification | Ad hoc / manual | Systemwide workflow | Automated pre-season eligibility sweep |
| ICD-10 Crosswalk Audit Cycle | Annual / reactive | Quarterly / proactive | Within 2 weeks of October 1 each year |
Veradigm data shows that hospitals now employ nearly 6 in 10 physicians, and corporate entities have overtaken hospitals as the leading practice owner (33.2% vs. 30.6%). Since 2024, 48,100 physicians left independent practice and 13,900 additional practices were acquired. Yet 26% of practices that advanced to serious acquisition negotiations chose to remain independent — suggesting the RCM and financial execution gap is the primary driver of consolidation pressure, not preference.
Practices in the 24% that have revenue visibility — real-time dashboards by payer, A/R aging, denial category, and coding performance — consistently perform closer to health system benchmarks. The 76% that lack visibility are not failing because independence is unviable; they are failing because they are operating without the financial instrumentation that system practices have had for years.
The three RCM investments with the highest independence-preservation ROI for a solo or small-group practice are: (1) a real-time A/R dashboard with denial categorization, (2) automated eligibility verification at scheduling, and (3) a monthly ICD-10 remit audit cycle. Each costs less than one clinical FTE and protects a disproportionate share of revenue.
| Specialty | Key Update | Action Required |
|---|---|---|
| Primary Care | UHC and Humana MA plan exits affect high proportions of PCP patient panels; open enrollment ends December 7; MA patients represent 47.4% of Medicare nationally | Begin MA patient re-verification workflow now; complete before December 7 for all active MA members |
| Cardiology | High-cost diagnostics and complex procedural coding drive disproportionate PA volume; FHIR PA standards now live as of October 1 | Review top 20 cardiology codes for PA requirements under post-October 1 payer rules; map to FHIR PA workflow for January 1 |
| Orthopedics | Global surgery periods and modifier application (59/XS/XU/XP) are primary audit trigger; payer scrutiny on modifier combinations intensified in 2026 | Conduct a modifier 59 audit on all orthopedic October claims; verify global period tracking for all surgical cases |
| Oncology | D05 breast cancer code change (no longer dual-code D05 + C50) took effect October 1; all October breast cancer claims carry potential coding logic errors if not updated | Run a D05+C50 dual-code audit on all October oncology claims immediately; update EHR code templates |
| Radiology | Aetna September 2026 radiology payment reduction (~15%) now in effect; billing teams reporting unexpected remittance variances | Reconcile expected vs. actual Aetna radiology remittances for September and October; escalate underpayment disputes within 90-day window |
| Mental Health / Behavioral Health | MA plan exits from UHC and Humana heavily affect BH panels; enrollment continuity is a critical patient-care and billing concern | Identify behavioral health patients in discontinued UHC/Humana MA plans; prioritize for December re-enrollment support before benefit disruption |
| Gastroenterology | UHC ended advance notification requirements for select GI endoscopy services for commercial members October 1, 2026 | Remove GI endoscopy advance notification step from commercial UHC workflows; confirm this does not apply to MA or exchange plan GI claims |
| Neurology | FHIR standards now support structured PA requests for high-cost neuro diagnostics (MRI, EEG, EMG) effective October 1 | Confirm EHR/PM vendor FHIR PA support is active for neurology diagnostics; test transactions before January 1 deadline |
Primary Care: MA patients represent an average of 47.4% of Medicare beneficiaries nationally — the highest concentration in any specialty’s panel. With UHC and Humana exiting plans for nearly 1 million members, primary care practices face the largest absolute re-verification burden of any specialty this open enrollment season.
Oncology — Breast Cancer: The D05 code change is a direct revenue integrity issue. Any October claim carrying both D05.x and C50.x will likely generate a claim adjustment reason code. This is a time-sensitive audit: every day of delay adds more claims to the remediation queue.
Orthopedics: Global period billing errors are in the top five orthopedic audit triggers nationally. The current payer scrutiny on modifier 59 applications makes a quarterly global period audit a standard of care for orthopedic billing compliance in 2026.